Image Source: Unsplash

Last week Senate Majority Leader Chuck Schumer stated that he would be delaying the introduction of the Cannabis Administration & Opportunity Act (CAOA) from the end of April until sometime before the end of July. That was not what investors wanted to hear and they continued to dump their Canadian (LP) and American (MSO) stocks to the cumulative tune of 27.4% in April.

The Canadian Pure-play LP Pot Stock Index

This article highlights the performance of the Canadian Pure-play LP Pot Stock Index (the performance of the American Pure-play MSO Pot Stock Index is highlighted in my previous article here) in April, YTD, and from its peak in February of 2021, as follows, in descending order:.

(You will note that each constituent in the analyses below has 5 areas of additional information that are imperative for any individual considering investing in this sector:

1. The company name is hyperlinked to its website to provide you with a description of the company and an analysis of its stock.
2. The trading symbol is hyperlinked to additional financial data and commentary on the company (where available).
3. The Chance of Financial Distress percentage is sourced from macroaxis.com (click on link below).
4. The Analyst Consensus is sourced from stockanalysis.com (click on link below).
5. The articles are sourced from a number of sources to provide you with the best insights available.

1. Organigram (OGI): DOWN 15.1% in April; (-19.4% YTD);  -76.5% from its peak in 2021
   • Chance of Financial Distress in next 2 years: less than 1%
   • Analyst Consensus: 17 stock analysts currently rate OGI as a BUY
   • Recent Analysis/Commentary:
     • Organigram Q2 Financials Reveal Major Loss In Net Profit Vs. Q1
     • OrganiGram: Canadian Cannabis Remains Tough To Own
2. Cronos (CRON): DOWN 22.3%; (-23.0% YTD);  -80..6% from its 2021 peak
   • Chance of Financial Distress in next 2 years: less than 1%
   • Analyst Consensus: 20 stock analysts currently rate CRON as a SELL
   • Recent Analysis/Commentary: 
     • Cronos Group Q3 Financial Results Show Major Improvement
3. Aurora (ACB): DOWN 24.3%;  (-44.0% YTD); -84.0% from its 2021 peak
   • Chance of Financial Distress in next 2 years: 49%
   • Analyst Consensus: 18 stock analysts currently rate ACB as a SELL
   • Recent Analysis/Commentary:
     • Aurora Cannabis CEO 'Absolutely Confident' Company Will Be EBITDA-Positive By Year's End
4. Canopy Growth (CGC): DOWN 24.7%; (-35.6% YTD);  -89.1% from its 2021 peak
   • Chance of Financial Distress in next 2 years: +67%
   • Analyst Consensus: 26 stock analysts currently rate CGC as a SELL
   • Recent Analysis/Commentary:
     • Is Canopy Growth a Buy After its Announcement to Cut Costs?
     • Canopy Growth Reports Horrible Q3 Financial Results
5. Tilray (TLRY): DOWN 35.9%; (-29.2% YTD); -92.2% from its 2021 peak
   • Chance of Financial Distress in next 2 years: +67%
   • Analyst Consensus: 26 stock analysts currently rate TLRY as a HOLD
   • Recent Analysis/Commentary:
     • Tilray Q3 Cannabis Revenue Declines 6% Sequentially to $55 Million
     • Tilray: Keeping Competition Alive

The Canadian Pure-play LP Pot Stock Index went DOWN 27.1% in April and is now DOWN 32.4% YTD and DOWN 88.4% from its high in 2021.

For the record:

• The American Pure-play MSO Pot Stock Index went DOWN 27.7% in April (detail here) and is now DOWN 38.6% YTD and is now DOWN 71.7% from its high in 2021.
• Collectively, the Canadian LP and American MSO indices went DOWN 27.4% in April and are now DOWN 37.4% YTD and -78.0% from their highs in 2021.